Cargando…
Cost-Effectiveness of Hepatitis B Vaccination in Adults With Diagnosed Diabetes
OBJECTIVE: To examine the cost-effectiveness of a hepatitis B vaccination program for unvaccinated adults with diagnosed diabetes in the U.S. RESEARCH DESIGN AND METHODS: We used a cost-effectiveness simulation model to estimate the cost-effectiveness of vaccinating adults 20–59 years of age with di...
Autores principales: | Hoerger, Thomas J., Schillie, Sarah, Wittenborn, John S., Bradley, Christina L., Zhou, Fangjun, Byrd, Kathy, Murphy, Trudy V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526214/ https://www.ncbi.nlm.nih.gov/pubmed/22933435 http://dx.doi.org/10.2337/dc12-0759 |
Ejemplares similares
-
Immune Response of Hepatitis B Vaccine Among Persons With Diabetes: A systematic review of the literature
por: Schillie, Sarah F., et al.
Publicado: (2012) -
Antiviral Treatment among Pregnant Women with Chronic Hepatitis B
por: Fan, Lin, et al.
Publicado: (2014) -
A Cost-Benefit Analysis of Lipid Standardization in the United States
por: Hoerger, Thomas J., et al.
Publicado: (2011) -
Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes
por: Li, Rui, et al.
Publicado: (2010) -
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
por: Schillie, Sarah, et al.
Publicado: (2018)